Pfizer completes $15B acquisition of Hospira

By Associated Press  |  September 03, 2015

Drugmaker Pfizer says it has completed its roughly $15 billion purchase of the injectable-drug maker and infusion-device manufacturer Hospira, expanding its product offerings in a growing medical market.

Pfizer says Hospira purchase will close in early September

By Associated Press  |  August 24, 2015

Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion devicemaker Hospira, and says the deal will close in early September. The FTC has ordered Pfizer to sell four drugs in order to preserve competition.

Pfizer sales, earnings still in patent-cliff plunge

By Steven Ross Johnson  |  July 28, 2015

Pharmaceutical giant Pfizer on Tuesday reported continuing declines in sales and earnings as it girds for the loss of patent protection in Europe and Japan of Enbrel, its rheumatoid arthritis drug.

Florida hospital testing new snake anti-venom

By Associated Press  |  July 04, 2015

Florida Hospital DeLand is one of three hospitals in the state testing an experimental anti-venom for coral snake bites. The brightly colored snake rarely bites, but just a drop of its venom is a lethal dose.

Blockbuster drugs to drain payers' finances, report says

By Bob Herman  |  June 09, 2015

The costs of prescription drugs have grown more quickly than any other part of the healthcare industry, and a new report estimates a small portion of breakthrough specialty drugs will further strain the budgets of federal and state healthcare programs.

Novartis still biggest drugmaker; Gilead sees huge growth

By Michael Sandler  |  May 23, 2015

A strong sales year for its prescription products and participation in emerging markets enabled Novartis Corp. to maintain its position as the largest pharmaceutical company in 2014. Meanwhile, Actavis saw a 50.5% revenue increase, and Biogen's revenue grew by 40%.

New meds help drugmakers weather strong dollar, other issues

By Associated Press  |  April 28, 2015

Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer, Merck & Co. and Bristol-Myers Squibb Co., which reported first-quarter results Tuesday, all derive at least half their...

The Top 25 Women in Healthcare: Gender diversity a work in progress

The Top 25 Women in Healthcare: Gender diversity a work in progress

By Melanie Evans  |  April 25, 2015

For women who aspire to healthcare's executive-level roles, advanced education and the willingness to take risks may not be enough. Surveys of corporate leadership and healthcare management point to a continued, though narrowing, disparity of women to men in leadership roles.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.